Picture of Accolade logo

ACCD Accolade News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Accolade Inc expected to post a loss of 74 cents a share - Earnings Preview

* Accolade Inc  ACCD.OQ   ACCD.O  is expected to show a rise in
quarterly revenue when it reports  results on January 10. 
* The Plymouth Meeting Pennsylvania-based  company is expected
to report  a 97.4% increase in revenue to $75.89 million from
$38.44 million a year ago, according to the mean estimate from
11 analysts, based on Refinitiv data. 
​* Refinitiv's mean analyst estimate for Accolade Inc is for a
loss of 74 cents per share. For the same quarter last year, the
company reported a loss of 32 cents per share.
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 12 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Accolade Inc is
$51​, about 58.1% above​ its last closing price of $21.39. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Aug. 31 2021  -0.58       -0.56      -0.97     Missed  -72.5
 May. 31 2021  -0.37       -0.37      -0.66     Missed  -79.8
 Feb. 28 2021  -0.10       -0.10      -0.22     Missed  -121.8
                                                        ​
 Nov. 30 2020  -0.35       -0.35      -0.32     Beat    8.2
 ​​Aug.        -0.40       -0.40      -0.47     Missed  -16.4
 31 2020                                                
 May. 31 2020  -0.40       -0.40      -1.69     Missed  -322.5
                                                        ​
 This summary was machine generated January 7 at 21:06 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on Accolade

See all news